Increased serum S-100B and neuron specific enolase - Potential markers of early nervous system involvement in essential hypertension

Clinical Biochemistry

Volumn 44, Issue 2-3, 2011, Pages 154-159

  González Quevedo, Alina ^a   García, Sergio González ^a   Concepción, Otman Fernández ^a   Freixas, Rosaralis Santiesteban ^a   Sotolongo, Luis Quevedo ^b   Menéndez, Maria Caridad ^a   Sánchez, Marisol Peña ^a   Almirall, Isabel Fernández ^a   Carriera, Rebeca Fernández ^a   Díaz, Zenaida Hernández ^a   Menéndez, Keiny ^a  

^a INSTITUTO DE NEUROLOGÍA Y NEUROCIRUGÍA   (Cuba)

^b Clinica Central Cira Garcia   (Cuba)

Author keywords

Cerebrovascular disease; Hypertension; Magnetic resonance imaging (MRI); Neuron specific enolase; Retinopathy; S 100B

Indexed keywords

BIOLOGICAL MARKER; NEURON SPECIFIC ENOLASE; PROTEIN S100B; ENOLASE; PROTEIN S 100;

ADULT; ARTICLE; BRAIN DAMAGE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; IMMUNOASSAY; MALE; MULTIVARIATE ANALYSIS; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RETINOPATHY; WHITE MATTER; BLOOD; HYPERTENSION;

BIOMARKERS; HUMANS; HYPERTENSION; PHOSPHOPYRUVATE HYDRATASE; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S100 PROTEINS;

EID: 79151479771     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.11.006     Document Type: Article

References (30)

1. Mancia G., Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187.
2. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003, 289:2560-2572.
3. Henskens L.H., Van Oostenbrugge R.J., Kroon A.A., Hofman P.A., Lodder J., De Leeuw P.W. Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients. J Hypertens 2009, 27:846-853.
4. Al-Sarraf H., Philip L. Effect of hypertension on the integrity of blood brain and blood CSF barriers, cerebral blood flow and CSF secretion in the rat. Brain Res 2003, 975:179-188.
5. Amenta F., Di Tullio M.A., Tomassoni D. Arterial hypertension and brain damage - evidence from animal models (Review). Clin Exp Hypertens 2003, 25:359-380.
6. Ohira T., Shahar E., Chambless L.E., Rosamond W.D., Mosley T.H., Folsom A.R. Risk factors for ischemic stroke subtypes. The Atherosclerosis Risk in Communities Study. Stroke 2006, 37:2493-2498.
7. Poulet R., Gentile M.T., Vecchione C., Distaso M., Aretini A., Fratta L., et al. Acute hypertension induces oxidative stress in brain tissues. J Cerebr Blood F Met 2006, 26:253-262.
8. Ueno M., Sakamoto H., Liao Y.J., Onodera M., Huang C.L., Miyanaka H., et al. Blood-brain barrier disruption in the hypothalamus of young adult spontaneously hypertensive rats. Histochem Cell Biol 2004, 122:131-137.
9. Ishida H., Takemori K., Dote K., Ito H. Expression of glucose transporter-1 and aquaporin-4 in the cerebral cortex of stroke-prone spontaneously hypertensive rats in relation to the blood-brain barrier function. Am J Hypertens 2006, 19:33-39.
10. Marchi N., Rasmussen P., Kapural M., Fazio V., Kight K., Mayberg M.R., et al. Peripheral markers of brain damage and blood-brain barrier dysfunction. Restor Neurol Neuros 2003, 21:109-121.
11. Selakovic V., Raicevic R., Radenovic L. The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction. J Clin Neurosci 2005, 12:542-547.
12. Gottesman R.F., Wityk R.J. Brain injury from cardiac bypass procedures. Semin Neurol 2006, 26:432-439.
13. Dassan P., Keir G., Brown M.M. Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B. Cerebrovasc Dis 2009, 27:295-302.
14. Shinozaki K., Oda S., Sadahiro T., Nakamura M., Hirayama Y., Abe R., et al. S-100B and neuron-specific enolase as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation: a systematic review. Crit Care 2009, 13:1-12. 10.1186/cc7973.
15. De Leeuw F.E., De Groot J.C., Oudkerk M., Witteman J.C., Hofman A., Van Gijn J., et al. Hypertension and cerebral WML in a prospective cohort study. Brain 2002, 125:765-772.
16. Kitagawa K. Cerebral blood flow measurement by PET in hypertensive subjects as a marker of cognitive decline. J Alzheimers Dis 2010, 20:855-859.
17. De Quesada-Martínez M.E., Blanco-García M., Díaz-De Quesada L. Early functional disorders of the brain in uncomplicated hypertensive patients. Rev Neurol 2005, 40:199-209.
18. Angelini A., Bendini C., Neviani F., Bergamini L., Manni B., Trenti T., et al. Insulin-like growth factor-1 (IGF-1): relation with cognitive functioning and neuroimaging marker of brain damage in a sample of hypertensive elderly subjects. Arch Gerontol Geriatr 2009, 49(Suppl 1):5-12.
19. Schmidt A.P., Tort A.B.L., Amaral O.B., Schmidt A.P., Walz R., Vettorazzi-Stuckzynski J., et al. Serum S100B in pregnancy-related hypertensive disorders: a case-control study. Clin Chem 2004, 50:435-438.
20. Al-Rawi N.H., Atiyah K.M. Salivary neuron specific enolase: an indicator for neuronal damage in patients with ischemic stroke and stroke-prone patients. Clin Chem Lab Med 2009, 47:1519-1524.
21. Mayer S.A., Linares G. Can a simple blood test quantify brain injury? Crit Care 2009, 13:166-167.
22. Laskowitz D.T., Kasner S.E., Saver J., Remmel K.S., Jauch E.C., BRAIN Study Group Clinical Usefulness of a Biomarker-Based Diagnostic Test for Acute Stroke: The Biomarker Rapid Assessment in Ischemic Injury (BRAIN) Study. Stroke 2009, 40:77-85.
23. Kleine T.O., Benes L., Zöfel P. Studies of the brain specificity of S100B and neuron-specific enolase (NSE) in blood serum of acute care patients. Brain Res Bull 2003, 61:265-279.
24. Van Munster B.C., Korse C.M., De Rooij S.E., Bonfrer J.M., Zwinderman A.H., Korevaar J.C. Markers of cerebral damage during delirium in elderly patients with hip fracture. BMC Neurol 2009, 9:21. 10.1186/1471-2377-9-21.
25. Konstantinou E.A., Venetsanou K., Mitsos A.P., Mamoura K.V., Theodosopoulou E.E., Fotis T., et al. Neuron specific enolase (NSE): a valuable prognostic factor of central nervous system dysfunction following cardiac surgery. Brit J Anaesth Recov Nurs 2008, 9:22-28.
26. Perloff D., Grim C., Flack J., Frohlich E.D., Hill M., McDonald M., et al. Human blood pressure determination by sphygmomanometry. Circulation 1993, 88:2460-2470.
27. Scheie H.G. Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis. AMA Arch Ophthalmol 1953, 49:117-138.
28. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MR signal abnormalities at 1.5T in Alzheimer's dementia and normal aging. Am J Roentgenol 1987, 149:351-356.
29. Henskens L.H., Kroon A.A., Van Oostenbrugge R.J., Gronenschild E.H., Hofman P.A., Lodder J., et al. Associations of ambulatory blood pressure levels with white matter hyperintensity volumes in hypertensive patients. J Hypertens 2009, 27:1446-1452.
30. Oertel M., Schumacher U., McArthur D.L., Kästner S., Böker D.-K. S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome. J Clin Neurosci 2006, 13:834-840.